Skip to main content
. 2021 Jun 15;11:12514. doi: 10.1038/s41598-021-91682-6

Figure 6.

Figure 6

PLNC8 αβ inhibits S. aureus growth and bacteria-induced cytotoxicity of human keratinocytes. HaCaT cells were infected with MSSA, in the presence or absence of PLNC8 αβ for 93 h. PLNC8 αβ inhibited S. aureus growth at (A) MOI:0.1 and (B) MOI:1 in a dose-dependent manner for at least 93 h, and markedly enhanced the effect of low dose gentamicin. S. aureus caused cell death after 11 h (MOI:0.1) and 7 h (MOI:1), as indicated by the dotted lines and markers below each graph. PLNC8 αβ efficiently counteracted this effect in a dose-dependent manner. The combination of PLNC8 αβ with gentamicin synergistically inhibited S. aureus growth and counteracted bacteria-induced cell death. The y-axis represents fluorescence intensity expressed as arbitrary units (AU/well).